Biomarkers add value to traumatic brain injury prognosis

Stuart J McDonald¹, Terence J O'Brien¹, Sandy R Shultz²

Affiliations

¹ Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC 3004, Australia; Department of Neurology, Alfred Health, The Alfred Hospital, Melbourne, VIC, Australia.
² Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC 3004, Australia; Department of Neurology, Alfred Health, The Alfred Hospital, Melbourne, VIC, Australia; Health and Human Services, Vancouver Island University, Nanaimo, BC, Canada. Electronic address: sandy.shultz@monash.edu.

PMID: 35963248
DOI: 10.1016/S1474-4422(22)00306-4

Comment

Biomarkers add value to traumatic brain injury prognosis

Stuart J McDonald et al. Lancet Neurol. 2022 Sep.

. 2022 Sep;21(9):761-763.

doi: 10.1016/S1474-4422(22)00306-4.

Authors

Stuart J McDonald¹, Terence J O'Brien¹, Sandy R Shultz²

Affiliations

¹ Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC 3004, Australia; Department of Neurology, Alfred Health, The Alfred Hospital, Melbourne, VIC, Australia.
² Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC 3004, Australia; Department of Neurology, Alfred Health, The Alfred Hospital, Melbourne, VIC, Australia; Health and Human Services, Vancouver Island University, Nanaimo, BC, Canada. Electronic address: sandy.shultz@monash.edu.

PMID: 35963248
DOI: 10.1016/S1474-4422(22)00306-4

No abstract available

PubMed Disclaimer

Conflict of interest statement

TJO declares investigator-initiated research payments and consultancy fees paid to his institution from Eisai, UCB, Supernus, Biogen, ES Therapeutics, Epidarex, LivaNova, and Kinoxis Therapeutics; and payments to his institution for participation on an advisory board from ES Therapeutics and Kinoxis Therapeutics. SRS and SJM declare no competing interests.

Comment on

Incremental prognostic value of acute serum biomarkers for functional outcome after traumatic brain injury (CENTER-TBI): an observational cohort study.
Helmrich IRAR, Czeiter E, Amrein K, Büki A, Lingsma HF, Menon DK, Mondello S, Steyerberg EW, von Steinbüchel N, Wang KKW, Wilson L, Xu H, Yang Z, van Klaveren D, Maas AIR; CENTER-TBI participants and investigators. Helmrich IRAR, et al. Lancet Neurol. 2022 Sep;21(9):792-802. doi: 10.1016/S1474-4422(22)00218-6. Lancet Neurol. 2022. PMID: 35963262
Prognostic value of day-of-injury plasma GFAP and UCH-L1 concentrations for predicting functional recovery after traumatic brain injury in patients from the US TRACK-TBI cohort: an observational cohort study.
Korley FK, Jain S, Sun X, Puccio AM, Yue JK, Gardner RC, Wang KKW, Okonkwo DO, Yuh EL, Mukherjee P, Nelson LD, Taylor SR, Markowitz AJ, Diaz-Arrastia R, Manley GT; TRACK-TBI Study Investigators. Korley FK, et al. Lancet Neurol. 2022 Sep;21(9):803-813. doi: 10.1016/S1474-4422(22)00256-3. Lancet Neurol. 2022. PMID: 35963263 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Biomarkers add value to traumatic brain injury prognosis

Affiliations

Biomarkers add value to traumatic brain injury prognosis

Authors

Affiliations

Conflict of interest statement

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical